Transcat (TRNS) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Transcat

NasdaqGM•Industrials•Specialty Business Services

$84.31+1.95(0.02%)Pre-market

Market Cap

$804.36M

P/E

233.4x

P/S

2.3x

P/B

2.7x

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. The company operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control, and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value-added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense, industrial manufacturing, energy and utilities, oil and gas, chemical manufacturing, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. It also provides calibration, repair, preventive maintenance, electrical safety inspection, and documentation and regulatory compliance services to hospital networks and healthcare facilities in the southeastern United States. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.

How this company scores

AverageMetricSide Score: 53/100

Strongest: Cash & Earnings Quality (24/25); weakest: Profitability (4/25).

Profitability4/25

Growth13/25

Balance Sheet & Red Flags12/25

Cash & Earnings Quality24/25

Strengths

Growing revenueRising free cash flowLow leverageCash-backed earnings

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 233.4x5y range 0.0x – 233.4x

Currently above its 20-quarter median.

P/S · 2.3x5y range 0.0x – 3.8x

Currently near its 20-quarter median.

P/B · 2.7x5y range 0.0x – 8.4x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

Operating margins dropped 46.4% over recent quarters — a sharp decline suggesting serious cost or pricing challenges.

Leverage Risk

Watch

Debt-to-equity has risen 221.3% recently — increasing financial risk even if the current ratio is manageable.

Price & Volume

Market Cap $804.36M

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $348.40M
Q. Revenue: $92.94M
TTM EBITDA: $39.17M
TTM Op. Income: $11.64M
Q. Op. Income: $3.72M
TTM Net Income: $3.45M
Q. Net Income: $1.33M
EPS: $0.14
Shares Out.: $9.35M

$348.40M in TTM revenue grew 20.9% YoY, reaching $92.94M last quarter. TTM EBITDA of $39.17M and TTM operating income of $11.64M show growth is flowing through to the bottom line. TTM net income of $3.45M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 5 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 33.1%
EBITDA Margin: 11.5%
Op. Margin: 4.0%
Net Margin: 1.4%

Op. margin of 4.0% is down 3.0% YoY — costs are rising relative to revenue. Net margin at 1.4% and gross margin of 33.1% show how much of each revenue dollar survives to profit. Over the past year, operating margin is down 43% — a weakening trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 233.4x
P/S Ratio: 2.3x
P/B Ratio: 2.7x

At 233.4x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 2.3x and P/B of 2.7x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Across the last 8 quarters, P/E has risen for 5 consecutive quarters — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $492.63M
Cash: $6.71M
Long-Term Debt: $110.39M
Book Value: $302.90M
D/E Ratio: 0.4
Debt/EBITDA: 10.3

With $492.63M in assets and $110.39M in long-term debt, D/E is 0.4and book value is $302.90M — a conservative capital structure with a cushion to weather downturns. Over the past year, debt/equity is up 221% — a weakening trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $8.82M
TTM Free Cash Flow: $25.36M
FCF Margin: 7.3%
FCF / Net Income: 7.4

TTM FCF of $25.36M on $8.82M in operating cash flow. The FCF / Net Income ratio of 7.4x means free cash flow covers net income — earnings are backed by cash. Over the past year, free cash flow is up 30% — an improving trend.